Literature DB >> 24356295

Feasibility of using vessel-detection software for the endovascular treatment of visceral arterial bleeding.

Jin Iwazawa1, Shoichi Ohueo, Naoko Hashimoto, Takashi Mitani.   

Abstract

We aimed to investigate the feasibility of using vessel-detection software to identify damaged arteries during endovascular embolization in five patients with visceral arterial hemorrhages. We used a software program originally developed to detect tumor feeder vessels in liver tumor embolization with C-arm computed tomography datasets to detect the vessels responsible for the arterial hemorrhages in patients with splenic artery pseudoaneurysms (n=2), lower gastrointestinal bleeding (n=2), and bladder tumor bleeding (n=1). In all cases, the injured vessel was identified accurately on a three-dimensional vascular map at the optimal working angle with a relatively short mean processing time of 118 s (range, 107-136 s). The operating angiographers used this information to direct the catheter into the damaged artery without sequential angiographic runs. The software analysis was also used to plan coil delivery to the most appropriate site in the injured artery. The results suggest that the vessel-detection software for liver tumor embolization can also be used to detect damaged vessels and to plan treatment strategies in endovascular embolization of visceral arterial hemorrhage.

Entities:  

Mesh:

Year:  2014        PMID: 24356295      PMCID: PMC4463308          DOI: 10.5152/dir.2013.13267

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  5 in total

1.  Clinical utility and limitations of tumor-feeder detection software for liver cancer embolization.

Authors:  Jin Iwazawa; Shoichi Ohue; Naoko Hashimoto; Osamu Muramoto; Takashi Mitani
Journal:  Eur J Radiol       Date:  2013-06-03       Impact factor: 3.528

2.  Detection of hepatocellular carcinoma: comparison of angiographic C-arm CT and MDCT.

Authors:  Jin Iwazawa; Shoichi Ohue; Naoko Hashimoto; Hisashi Abe; Masao Hamuro; Takashi Mitani
Journal:  AJR Am J Roentgenol       Date:  2010-10       Impact factor: 3.959

3.  Management and outcome of hemorrhage due to arterial pseudoaneurysms in pancreatitis.

Authors:  Hendrik Bergert; Irene Hinterseher; Stephan Kersting; Johannes Leonhardt; Aaron Bloomenthal; Hans Detlev Saeger
Journal:  Surgery       Date:  2005-03       Impact factor: 3.982

4.  Percutaneous embolotherapy of lower gastrointestinal hemorrhage.

Authors:  D J Peck; R F McLoughlin; M N Hughson; R N Rankin
Journal:  J Vasc Interv Radiol       Date:  1998 Sep-Oct       Impact factor: 3.464

5.  Computed analysis of three-dimensional cone-beam computed tomography angiography for determination of tumor-feeding vessels during chemoembolization of liver tumor: a pilot study.

Authors:  Frederic Deschamps; Stephen B Solomon; Raymond H Thornton; Pramod Rao; Antoine Hakime; Viseth Kuoch; Thierry de Baere
Journal:  Cardiovasc Intervent Radiol       Date:  2010-12       Impact factor: 2.740

  5 in total
  3 in total

1.  Cone beam computed tomography improves the detection of injured vessels and involved vascular territories in patients with bleeding of uncertain origin.

Authors:  Ulrich Grosse; Roland Syha; Dominik Ketelsen; Rüdiger Hoffmann; Sasan Partovi; Tarun Mehra; Konstantin Nikolaou; Gerd Grözinger
Journal:  Br J Radiol       Date:  2018-06-12       Impact factor: 3.039

2.  The utility of using TACE-assisted software with CBCT in colonic diverticular bleeding without extravascular leakage.

Authors:  Masahiro Nakano; Kazuki Takano; Atsuro Kaga; Keisuke Tsujibayashi; Yukiya Kitajima; Hiroaki Sato
Journal:  Radiol Phys Technol       Date:  2022-05-04

Review 3.  New advances in lower gastrointestinal bleeding management with embolotherapy.

Authors:  Anna Maria Ierardi; Josè Urbano; Giuseppe De Marchi; Camilla Micieli; Ejona Duka; Francesca Iacobellis; Federico Fontana; Gianpaolo Carrafiello
Journal:  Br J Radiol       Date:  2016-02-04       Impact factor: 3.039

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.